Key Agenda Items
The Board of Directors meeting is scheduled for Saturday, 14 November 2026. The primary agenda is to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half-year ended 30 September 2026. The board will also review the accompanying Statement of Assets and Liabilities, Cash Flow Statement, and the Limited Review Report.
Trading Window Closure
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Internal Procedures and Conduct, the trading window for dealing in the company's shares has been closed for all Designated Persons and their immediate relatives. The closure period began on 1 October 2026 and will remain in effect until 48 hours after the announcement/declaration of the financial results.
Trading Suspension Status
Trading in the company's securities on both BSE Limited and National Stock Exchange of India Limited remains suspended. This suspension is on account of a liquidation order received by the company, referenced as 3.1.A 259/2022 IN C.P.(IB)-1890(MB)/2018 dated 9 February 2022.
Financial Impact
Financial impact not quantified in the disclosure.